133 related articles for article (PubMed ID: 14994738)
1. A breakthrough case of hepatitis A disease following a full vaccination schedule of three doses of a combined hepatitis A and B vaccine.
Nothdurft HD; Aumüller H; Aumüller R; Dames W; Stamer K; Kroetzsch H; Kulow M
Vaccine; 2004 Jan; 22(5-6):592-3. PubMed ID: 14994738
[No Abstract] [Full Text] [Related]
2. Hepatitis A+B vaccine in elderly persons.
Wiedermann G
J Travel Med; 2004; 11(2):130-2. PubMed ID: 15109485
[No Abstract] [Full Text] [Related]
3. Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines.
Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Sänger R
BioDrugs; 2003; 17 Suppl 1():15-8. PubMed ID: 12785873
[No Abstract] [Full Text] [Related]
4. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
Van Damme P; Van Herck K
Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
[TBL] [Abstract][Full Text] [Related]
5. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
6. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
Chlibek R; von Sonnenburg F; Van Damme P; Smetana J; Tichy P; Gunapalaiah B; Leyssen M; Jacquet JM
J Travel Med; 2011; 18(2):145-8. PubMed ID: 21366801
[TBL] [Abstract][Full Text] [Related]
7. A new accelerated vaccination schedule for rapid protection against hepatitis A and B.
Nothdurft HD; Dietrich M; Zuckerman JN; Knobloch J; Kern P; Vollmar J; Sänger R
Vaccine; 2002 Jan; 20(7-8):1157-62. PubMed ID: 11803077
[TBL] [Abstract][Full Text] [Related]
8. Ten-year antibody persistence induced by hepatitis A and B vaccine (Twinrix) in adults.
Van Herck K; Leroux-Roels G; Van Damme P; Srinivasa K; Hoet B
Travel Med Infect Dis; 2007 May; 5(3):171-5. PubMed ID: 17448944
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
[TBL] [Abstract][Full Text] [Related]
10. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
Proell S
BioDrugs; 2003; 17 Suppl 1():7-10. PubMed ID: 12785871
[No Abstract] [Full Text] [Related]
11. Persistence of antibodies 20 y after vaccination with a combined hepatitis A and B vaccine.
Van Damme P; Leroux-Roels G; Suryakiran P; Folschweiller N; Van Der Meeren O
Hum Vaccin Immunother; 2017 May; 13(5):972-980. PubMed ID: 28281907
[TBL] [Abstract][Full Text] [Related]
12. [Response to hepatitis A and hepatitis B vaccination: genetic differences].
Degos F
Gastroenterol Clin Biol; 2003 Apr; 27(4):429-30. PubMed ID: 12759691
[No Abstract] [Full Text] [Related]
13. Hepatitis A and B Vaccination in the United States.
Sanchez MC
R I Med J (2013); 2020 Aug; 103(6):44-46. PubMed ID: 32752566
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Controlled Trial to Evaluate a Potential Hepatitis B Booster Vaccination Strategy Using Combined Hepatitis A and B Vaccine.
Li F; Hu Y; Zhou Y; Chen L; Xia W; Song Y; Tan Z; Gao L; Yang Z; Zeng G; Han X; Li J; Li J
Pediatr Infect Dis J; 2017 May; 36(5):e157-e161. PubMed ID: 28060048
[TBL] [Abstract][Full Text] [Related]
15. Rapid and sustained immune response against hepatitis A and B achieved with combined vaccine using an accelerated administration schedule.
Connor BA; Blatter MM; Beran J; Zou B; Trofa AF
J Travel Med; 2007; 14(1):9-15. PubMed ID: 17241248
[TBL] [Abstract][Full Text] [Related]
16. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine.
Cardell K; Akerlind B; Sällberg M; Frydén A
J Infect Dis; 2008 Aug; 198(3):299-304. PubMed ID: 18544037
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of quadrivalent HPV and combined hepatitis A and B vaccine when co-administered or administered one month apart to 9-10 year-old girls according to 0-6 month schedule.
Gilca V; Sauvageau C; Boulianne N; De Serres G; Couillard M; Krajden M; Ouakki M; Murphy D; Trevisan A; Dionne M
Hum Vaccin Immunother; 2014; 10(8):2438-45. PubMed ID: 25424952
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the immunogenicity of combined hepatitis A and B vaccine by a prospective and retrospective trial.
Wolters B; Müller T; Ross RS; Clauberg R; Werfel U; Roggendorf H; Siggelkow C; Hausen T; Roggendorf M
Hum Vaccin; 2009 Apr; 5(4):248-53. PubMed ID: 19276678
[TBL] [Abstract][Full Text] [Related]
19. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
[TBL] [Abstract][Full Text] [Related]
20. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
Beran J
Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
